EU Commission President Ursula von der Leyen held a press conference with the President of the EU Council, Charles Michel, at the end of the first day’s meeting of the EU Leaders Summit, where the Covid-19 crisis was discussed.
Von der Leyen emphasized that the issue of vaccination certificate has been discussed in detail and that what such a document will be used for is “a political decision to be taken by each country itself”.
Stating that there is a need for information such as scientifically how the contagion is prevented, how long the vaccine provides protection, but promising results have started to come from countries such as Israel, von der Leyen said, He said that basic medical information such as where it is done will be found, the system should be integrated into health and border systems by EU countries.
“Studies for vaccination certification will take time and at least 3 months. So expectations are too early and not too high,” says Von der Leyen. said.
Noting that the certificate will also include information such as negative PCR test result, Covid-19 and whether it creates antibodies, apart from the vaccination information of the individuals, von der Leyen said, “If we want to implement such a certificate until the summer, member countries should not agree on the principles and the technology to be used, but on the health and border. It should act quickly in its distribution to control systems. ” he spoke.
“APPLE AND GOOGLE DO NOT FILL THE SPACE”
Von der Leyen stated that they should use a “European solution” when creating the certification system. “Otherwise, others will fill this gap. As far as we know, Apple and Google have proposed some solutions to the World Health Organization. We’re talking sensitive information here,” EU Commission President said. said.
Stating that the 3-month period for the preparation of the certification system is required for technical studies, von der Leyen said that they agreed on the data to be included in the certificate and that what the person holding the certificate could do was the main issue.
Von der Leyen stated that it is an option for people who do not have a vaccine certificate to have the same rights as those who have a negative PCR test result or a rapid antigen test.
8 PERCENT OF ADULT POPULATION IN THE EU EXCEEDED
While giving information about the vaccination in the EU, Von der Leyen said that 51 million doses of vaccine have been delivered so far, 29 million vaccines have been administered, which means 8 percent of the adult population.
Von der Leyen emphasized that he is of the opinion that the companies share their licenses “voluntarily” upon the question about the idea that vaccine licenses must be shared by companies.
MICEL: OUR PRIORITY IS TO ACCELERATE PRODUCTION AND SUPPLY
EU Council President Charles Michel said that they discussed issues such as vaccines, new variants, travel restrictions, vaccine certificates, international solidarity, lessons learned from the crisis, strengthening the health system and improving coordination in Europe.
Stressing that their priority is to accelerate vaccination, vaccine production and supply in EU countries, Michel said that they support the Commission’s efforts to overcome blockages and increase production by working with the sector on this issue.
Stating that vaccine procurement should be more predictable and transparent, Michel stated that pharmaceutical companies must comply with their commitments in vaccine agreements.
Stating that they are aware that about 400 different substances are used in Covid-19 vaccines, Michel stated that they will maintain contact with all partners in order to increase production and ensure supply chain security.
AŞI SERTİFİKASINDA “AYRIMCILIK” KAYGISI
Pointing out that they have dealt with the issue of vaccination certificates broadly, Michel said, “We have agreed to continue working to achieve a common approach. Here, more work is needed in areas such as digitization and cooperation with the World Health Organization. We will discuss the issue again at the next summit. said.
On a question about vaccination certificates, Michel said, “There are some unresolved issues about the certification. We have tasked the representatives to continue the work to determine a mutually usable certificate among member countries.” he spoke.
Emphasizing that a common European approach to certification should be demonstrated, Michel said that apart from the vaccine type and the date of vaccination, information such as PCR test, test date, immunity should be included, and this will make the certificate more useful.
“As regards certification, there are several concerns that some member states may discriminate between those who are legitimately vaccinated and those who are not. We expect progress in this area by the next meeting,” Michel said. used the expression.